Functional Dyspepsia Treatment Using Virtual Reality
Functional Dyspepsia
About this trial
This is an interventional treatment trial for Functional Dyspepsia
Eligibility Criteria
Inclusion Criteria: Symptoms of dyspepsia thought to represent functional dyspepsia, meeting Rome IV criteria Had an upper endoscopy and assessment for Helicobacter pylori; if a patient is found to have H. pylori, treatment with confirmed eradication (by stool antigen test or urea breath test) will be required before the patient is eligible for study inclusion. Patients will be considered for the study if they have undergone a complete history and physical examination during a previously scheduled consultation/evaluation visit with a gastroenterologist in the Mayo Clinic Florida General GI or Motility clinic. Exclusion Criteria: Symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis, inflammatory bowel disease, type I diabetes, a known malignancy, radiation-induced injury, an active infection, vasculitis, celiac disease), or patients have known uncontrolled GERD, esophagitis, eosinophilic esophagitis, or untreated H. pylori. Patients with gastroparesis or cyclic vomiting syndrome. Patients with prior surgery to the esophagus, stomach or duodenum. Patients taking opioids. Patients with motion sickness, vertigo, or a seizure disorder IBS symptoms are not predominant.
Sites / Locations
- Mayo Clinic in Florida
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Experimental
Sham
Experimental VR
Sham VR